Posted by Administrator on January 19th, 2006 — in Clarityn News
LORATIDINE LINKED TO BIRTH DEFECTS IN EUROPE
The European Medicines Evaluation Agency (EMEA) announced a safety review of Schering-Plough’s hayfever drug loratidine (Clarityn) after reports of an unusually high number of birth defects in children born to mothers who used the drug while pregnant.
GLAXO’S AVANDIA AND TAKEDA’S ACTOS GET STRENGTHENED CARDIOVASCULAR WARNINGS
GlaxoSmithKline and Takeda Pharmaceuticals […]
No Comments »
Posted by Administrator on January 19th, 2006 — in Clarityn News
There is an Arabic public T.V announcement that reminds viewers that good health cannot be purchased. However, the billion-dollar market of over-the-counter-drugs (OTCs) around the world shows that most people do not believe this. OTCs are convenient and most people consider them harmless. However, medical professionals have been concerned about the range and potential […]
No Comments »